Position in BBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$74,648,324
+$74,641,790 QoQ
Shares Held
1,002,260
+1138831.8% QoQ
Ownership
0.513%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#48
of 469 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIL Ltd holds $519,698,806 across 28 Biotechnology names. BBIO ranks #4 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
265,490 | $165,543,634 | |
| 2 | ASND |
Ascendis Pharma A/S
|
345,567 | $92,169,630 | |
| 3 | INSM |
INSMED Inc
|
856,214 | $91,289,536 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
This page
|
1,002,260 | $74,648,324 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
92,038 | $27,706,198 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
1,548,918 | $27,601,718 | |
| 7 | ARGX |
Argenx SE
|
16,249 | $15,075,334 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,508 | $13,167,318 |
All Filings in BBIO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,648,324 | 1,002,260 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,534 | 88 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||